Financial Network Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Financial Network Wealth Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$51K	Buy	66 +34	+106%	+$26K	0.05%	276
2025 Q4	$24.7K	Buy	32 +3	+10%	+$2.04K	0.03%	364
2025 Q3	$16.3K	Buy	29 +11	+61%	+$6.22K	0.02%	395
2025 Q2	$9.45K	Buy	18 +6	+50%	+$3.35K	0.01%	444
2025 Q1	$7.61K	Buy	12 +4	+50%	+$2.75K	0.01%	450
2024 Q4	$5.7K	Sell	8 -5	-38%	-$4.2K	0.01%	347
2024 Q3	$13.7K	Buy	13 +4	+44%	+$4.45K	0.01%	410
2024 Q2	$9.46K	Buy	+9	New	+$8.72K	0.01%	496

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Financial Network Wealth Advisors's REGN Position: Q1 2026 in Review

Financial Network Wealth Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 106% in Q1 2026, buying an estimated $26K and bringing the position to 66 shares worth $51K. The position accounts for 0.05% of the portfolio, ranked #276.

Financial Network Wealth Advisors first reported a position in REGN in Q2 2024 and has held it in 8 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Financial Network Wealth Advisors held 66 shares of Regeneron Pharmaceuticals worth $51K as of Q1 2026.
Financial Network Wealth Advisors bought 34 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $26K.
Regeneron Pharmaceuticals made up 0.05% of Financial Network Wealth Advisors's portfolio in Q1 2026, its #276 holding.
Financial Network Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.